951
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Assessment of patient-reported outcomes at 24 weeks of treatment with tralokinumab for atopic dermatitis: a multicentric real-life experience

, , , , , & show all
Article: 2285243 | Received 06 Nov 2023, Accepted 13 Nov 2023, Published online: 20 Nov 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.